Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Amesite is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments

  60% confidence

• The Company intends to use the net proceeds from the offerings for general corporate purposes, including working capital

  60% confidence

• NurseMagic™ is built on proprietary AI trained on industry-specific data, meets HIPAA regulations while improving accuracy and efficiency

  60% confidence

• NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance

  60% confidence

• The aggregate gross proceeds from the offerings are expected to be approximately $2 million, before deducting placement agent fees and other offering expenses

  60% confidence

• NurseMagic™ streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds

  60% confidence

• The NurseMagic™ platform serves B2B and B2C users across 50 states and 21 countries, offering translations to over 50 languages

  60% confidence

• The potential additional gross proceeds from the warrants, if fully exercised on a cash basis, will be approximately $4 million — no assurance can be given that any warrants will be exercised

  60% confidence

Cited in these Via News reports

• Enterprise AI Moves From Advice to Action Globally as Agentic Platforms Hit Production in 2026 →